Misha D. Serruya, John P. Donoghue*, Nicholas Hatsopoulos+, Richard Van Wagenen, K. Shane Guillory, Abe Caplan, Maryam Saleh, Dan Morris, Brian W. Hatt, Timothy R. Surgenor, Gerhard M Friehs++

Cyberkinetics, Inc., Foxboro, MA, and Salt Lake City, UT.* Brown University; +University of Chicago; ++Brown University and Rhode Island Hospital

BrainGate Neural Interface SystemPreclinical Proof of Concept

Transition to Human StudiesTransition to Human Studies

Braingate™ *: Developing a Device to Provide Motor Impaired Patients with A Novel Neural Output

Right Chart: Typing speed estimates were retrieved from the following two sources: http://www.cc.gatech.edu/classes/AY2003/cs4750b_spring/lectures/32 Hands Free Writing Software May Aid Disabled Users, Melissa Schor, AT Journal, Vol 56, September 1, 2002

*Note: The BrainGate is not a human investigational device in the United States. An IDE application has not yet been filled with the FDA. This poster is informational only and is intended to present the overall status of development of the product at Cyberkinetics Inc.

cerebral palsy

cerebellardisorders

locked-in syndrome

other stroke

spinal cord injury

spinal muscular atrophies

ALS

muscular dystrophy

limb loss

multiple sclerosis

Communication Requirements of Motor Impaired Patients

Right chart: Typing Speed Estimates were retrieved from the following two sources:http://www.cc.gatech.edu/classes/AY2003/cs4750b_spring/lectures/32Melissa Schor, Hands Free Writing Software May Aid Disabled Users, AT Journal, vol. 56, September 1 2002

Preclinical Safety

BrainGate Cart

BrainGate Cable Assembly

BrainGate Implant

BrainGateImplant

BrainGateCart

BrainGate CableAssembly